Testing Botox injections for eczema skin inflammation

This pilot study is testing whether Onabotulinum Toxin Type A (Botox) injections into eczema patches can help reduce inflammation and improve symptoms. Researchers believe that nerves in the skin release chemicals that keep eczema lesions active, and this medication may block those signals. By studying skin samples before and after treatment, scientists hope to understand new ways to treat eczema in the future.

Eczema is a chronic, uncomfortable skin condition that affects millions of people and significantly impacts quality of life. Early evidence suggests that the medication might help eczema by interrupting communication between nerves and immune cells in the skin, but this approach has not been thoroughly studied in eczema patients.